Title:
COMPOUND ISOLATED FROM MONASCUS PURPUREUS, PREPARATION METHOD THEREFOR AND USES THEREOF
Document Type and Number:
Japanese Patent JP2017105795
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for treatment or prophylaxis of dyslipidemia, hyperlipemia, hypercholesterolemia, or atherosclerosis.SOLUTION: The present invention discloses a pharmaceutical composition comprising a compound represented by the Formula II, separated from Monascus-fermented rice, and having the activity of inhibiting HMG-CoA reductase, and a pharmaceutically acceptable excipient thereof.SELECTED DRAWING: None
Inventors:
DUAN ZHENWEN
GUO SHUREN
LI XUEMEI
LIU CHUNLI
GUO SHUREN
LI XUEMEI
LIU CHUNLI
Application Number:
JP2017007646A
Publication Date:
June 15, 2017
Filing Date:
January 19, 2017
Export Citation:
Assignee:
BEIJING PEKING UNIV WBL BIOTECH CO LTD
International Classes:
C07D309/32; A61K9/02; A61K9/06; A61K9/08; A61K9/10; A61K9/12; A61K9/14; A61K9/16; A61K9/19; A61K9/20; A61K9/48; A61K9/72; A61K31/366; A61P1/14; A61P3/06; A61P9/00; A61P9/10; A61P11/10; A61P43/00
Domestic Patent References:
| JP2003521217A | 2003-07-15 | |||
| JP2005333973A | 2005-12-08 | |||
| JP2002537284A | 2002-11-05 |
Foreign References:
| CN101113146A | 2008-01-30 |
Other References:
ACTA PHARMACEUTICA SINICA, vol. 46, JPN6015048467, 2011, pages 564 - 567, ISSN: 0003726290
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 35, JPN6015048465, 26 June 2004 (2004-06-26), pages 1101 - 1112, ISSN: 0003726291
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 35, JPN6015048465, 26 June 2004 (2004-06-26), pages 1101 - 1112, ISSN: 0003726291
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Hidena Tsuda
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Hidena Tsuda